Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Future of Digital Experience: Key Insights for C-Level Execs
Digital experience isn't just about having an online presence anymore. For today's enterprises, it's a critical business enabler-it impacts everything from operational efficiency to…
|
Top 10 Customer Experience Trends in 2024
Customer experience (CX) has become a key business differentiator in shaping how businesses engage with their customers. As digital technologies continue to advance, they are driving significant…
|
Why WordPress Is The Best CMS For Your Business
Choosing the right Content Management System (CMS) for your business is crucial. A CMS not only affects your website's performance but also impacts your content strategy, SEO efforts, and…
|
Discover the Ultimate Free Copilot Solution
Are you also looking for Free Copilot? Then you are at the right place.I have been using the Github copilot but the only thing which was in mind is that it's paid, because I have been habitual…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
